Effective June 1, 2026, Corewell Health Microbiology Laboratory in Southeast Michigan is updating specimen collection criteria for body fluid specimens. Microbiology will no longer accept red top vacutainer tubes as a collection device for body fluids (i.e. synovial fluid, pleural fluid, peritoneal fluid, etc). Collection criteria information has been updated in Corewell’s Lab Test Directory to reflect this change. Test order for body fluid cultures is LAB2111016 (aerobic culture) and commonly accompanied by LAB233 (anaerobic culture).
Family Medicine
Changes to Outpatient Occult Blood (FIT) Stool Testing (Corewell Health Southwest Region)
Effective Tuesday, May 26, 2026, outpatient occult blood testing (stool) will no longer be performed at Corewell Health Lakeland St. Joseph Laboratory and will instead be routed or mailed to Corewell Health Reference Laboratory in Grand Rapids, MI (35 Michigan St.) for processing.
In addition, the collection kits will be updated from OC-Light™ S FIT collection kits to OC-Auto™ collection kits.
Effective Wednesday, April 29, 2026, Schistocyte Review (LAB1231565) will be available to order across all Corewell Health Laboratories Hematology Departments.
This new orderable supports alignment across Corewell Health regions by standardizing schistocyte assessment practices, ensuring high‑quality testing, and delivering a consistent patient care experience system‑wide.
Effective March 4, 2026, Corewell Health Laboratories in West Michigan will discontinue performing testosterone testing (LAB173 and LAB2111222) and Corewell Health Southwest Michigan will discontinue Testosterone Free and Total testing (LAB173)
The following replacements will be available as a send out to Quest Diagnostics:
⇒Testosterone, Total, MS – Epic Code: LAB1232313
⇒Testosterone, Free, Bioavailable and Total, MS – Epic Code: LAB1232237
Influenza prevalence fluctuates seasonally with the onset of “flu season” typically beginning its upswing in the month of December. It is important for providers to have an awareness of influenza prevalence (in addition to other respiratory viruses) to help guide when influenza testing should be pursued.
Improving Lupus Testing Accuracy: New Protocol Launching October 10, 2025
Effective October 10, 2025, Corewell Health Reference Laboratory West will implement an updated protocol for the Lupus Screen (LAB478). This change is designed to improve diagnostic accuracy for patients undergoing anticoagulant therapy, where false-positive or false-negative results can complicate clinical decision-making.
Effective Date: September 3, 2025
The MRSA Screen PCR [LAB1231076] detects the presence or absence of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and may be used to guide antimicrobial prophylaxis decisions. To improve and standardize test utilization across all Corewell Health regions, the following restrictions will be added to this test order:
- Ordering will be restricted to one test every 7 days.
- An indication for ordering must be provided for each order. Acceptable indications are:
- Pneumonia
- Skin and soft tissue (use for non-purulent infections)
- Surgical prophylaxis
Studies have shown that there is minimal utility in re-testing within 2 weeks as MRSA conversion rates are low and the PCR negative predictive values remain high for at least 14 days after initial testing.
Absence of nasal colonization with MRSA cannot be used to reliably rule out MRSA infection in scenarios other than those listed above.
Test Information
Vitamin D screening for deficiency/insufficiency will now be conducted via immunoassay. Current requests for Vitamin D2/D3 by Mass Spectrometry will be sent out.
For any questions or concerns, please contact the Corewell Health West Laboratory.
TEST INFORMATION
Discontinue: LAB1230925 25-Hydroxyvitamin D2 and D3, Serum
Replacement: LAB1231583 Vitamin D 25 Hydroxy
